Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study

Abstract : OBJECTIVE To assess the association between early and prolonged beta blocker treatment and mortality after acute myocardial infarction. DESIGN Multicentre prospective cohort study. SETTING Nationwide French registry of Acute ST- and non-STelevation Myocardial Infarction (FAST-MI) (at 223 centres) at the end of 2005. PARTICIPANTS 2679 consecutive patients with acute myocardial infarction and without heart failure or left ventricular dysfunction. MAIN OUTCOME MEASURES Mortality was assessed at 30 days in relation to early use of beta blockers (<= 48 hours of admission), at one year in relation to discharge prescription, and at five years in relation to one year use. RESULTS beta blockers were used early in 77% (2050/2679) of patients, were prescribed at discharge in 80% (1783/2217), and were still being used in 89% (1230/1383) of those alive at one year. Thirty day mortality was lower in patients taking early beta blockers (adjusted hazard ratio 0.46, 95% confidence interval 0.26 to 0.82), whereas the hazard ratio for one year mortality associated with beta blockers at discharge was 0.77 (0.46 to 1.30). Persistence of beta blockers at one year was not associated with lower five year mortality (hazard ratio 1.19, 0.65 to 2.18). In contrast, five year mortality was lower in patients continuing statins at one year (hazard ratio 0.42, 0.25 to 0.72) compared with those discontinuing statins. Propensity score and sensitivity analyses showed consistent results. CONCLUSIONS Early beta blocker use was associated with reduced 30 day mortality in patients with acute myocardial infarction, and discontinuation of beta blockers at one year was not associated with higher five year mortality. These findings question the utility of prolonged beta blocker treatment after acute myocardial infarction in patients without heart failure or left ventricular dysfunction.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01429191
Contributeur : Lnc - Université de Bourgogne <>
Soumis le : samedi 7 janvier 2017 - 11:00:39
Dernière modification le : mardi 20 octobre 2020 - 10:55:56

Lien texte intégral

Identifiants

Citation

Etienne Puymirat, Elisabeth Riant, Nadia Aissoui, Angèle Soria, Gregory Ducrocq, et al.. β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study. BMJ, BMJ Publishing Group, 2016, ⟨10.1136/bmj.i4801⟩. ⟨hal-01429191⟩

Partager

Métriques

Consultations de la notice

549